Cystic fibrosis airway epithelia fail to kill bacteria because of abnormal airway surface fluid

Cell

Volumn 85, Issue 2, 1996, Pages 229-236

  Smith, Jeffrey J ^a   Travis, Sue M ^a   Greenberg, E Peter ^a   Welsh, Michael J ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORIDE CHANNEL; CHLORIDE ION; SODIUM CHLORIDE;

AIRWAY DYNAMICS; ARTICLE; BACTERICIDAL ACTIVITY; BRONCHUS MUCUS; CONTROLLED STUDY; CYSTIC FIBROSIS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; INFECTION RISK; MOLECULAR BIOLOGY; PRIORITY JOURNAL; RESPIRATORY EPITHELIUM;

BACTERIA (MICROORGANISMS); BRONCHUS;

EID: 0029870085     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0092-8674(00)81099-5     Document Type: Article

References (42)

1. Balough, K., McCubbin, M., Weinberger, M., Smits, W., Ahrens, R., and Fick, R. (1995). The relationship between infection and inflammation in the early stages of lung disease from cystic fibrosis. Pediatr. Pulmonol. 20, 63-70.
2. Boucher, R.C., Knowles, M.R., Stutts, M.J., and Gatzy, J.T. (1983). Epithelial dysfunction in cystic fibrosis lung disease. Lung 161, 1-17.
3. Breeze, R.G., and Wheeldon, R.B. (1977). The cells of the pulmonary airways. Am. Rev. Respir. Dis. 116, 705-777.
4. Collins, F.S. (1992). Cystic fibrosis: molecular biology and therapeutic implications. Science 256, 774-779.
5. Davis, P.B. (1993). Pathophysiology of the lung disease in cystic fibrosis. In Cystic Fibrosis, P.B. Davis, ed. (New York: Marcel Dekker, Inc.), pp. 193-218.
6. DeKoster, J.A., and Thorne, P.S. (1995). Bioaerosol concentrations in noncomplaint, complaint, and intervention homes in the Midwest. Am. Ind. Hyg. Assoc. J. 56, 573-580.
7. Diamond, G., Jones, D.E., and Bevins, C.L. (1993). Airway epithelial cells are the site of expression of a mammalian antimicrobial peptide gene. Proc. Natl. Acad. Sci. USA 90, 4596-4600.
8. Engelhardt, J.F., Yankaskas, J.R., Ernst, S.A., Yang, Y., Marino, C.R., Boucher, B.C., Cohn, J.A., and Wilson, J.M. (1992). Submucosal glands are the predominant site of CFTR expression in the human bronchus. Nature Genet. 2, 240-248.
9. Fick, R.B., Jr., Naegel, G.P., Matthay, R.A., and Reynolds, H.Y. (1981). Cystic fibrosis pseudomonas opsonins: inhibitory nature in an in vitro phagocytic assay. J. Clin. Invest. 68, 899-914.
10. Gilljam, H., Ellin, A., and Strandvik, B. (1989). Increased bronchial chloride concentration in cystic fibrosis. Scand. J. Clin. Lab. Invest. 49, 121-124.
11. Goldstein, I.M., and Shak, S. (1994). Host defenses in the lung: neutrophils, complement, and other humoral mediators. In Textbook of Respiratory Medicine, J.F. Murray and J.A. Nadel, eds. (Philadelphia: W.B. Saunders), pp. 402-418.
12. Huxley, E.J., Viroslav, J., Gray, W.R., and Pierce, A.K. (1978). Pharyngeal aspiration in normal adults and patients with depressed consciousness. Am. J. Med. 64, 564-568.
13. Imundo, L., Barasch, J., Prince, A., and Al-Awqati, Q. (1995). Cystic fibrosis epithelial cells have a receptor for pathogenic bacteria on their apical surface. Proc. Natl. Acad. Sci. USA 92, 3019-3023.
14. Jiang, C., Finkbeiner, W.E., Widdicombe, J.H., McCray, P.B., Jr., and Miller, S.S. (1993). Altered fluid transport across airway epithelium in cystic fibrosis. Science 262, 424-427.
15. Joris, L., Dab, I., and Quinton, P.M. (1993). Elemental composition of human airway surface fluid in healthy and diseased airways. Am. Rev. Respir. Dis. 148, 1633-1637.
16. Khan, T.Z., Wagener, J.S., Bost, T., Martinez, J., Accurso, F.J., and Riches, D.W.H. (1995). Early pulmonary inflammation in infants with cystic fibrosis. Am. J. Respir. Crit. Care Med. 151, 1075-1082.
17. Knowles, M.R., Church, N.L., Waltner, W.E., Yankaskas, J.R., Gilligan, P., King, M., Edwards, L.J., Helms, R.W., and Boucher, R.C. (1990). A pilot study of aerosolized amiloride for the treatment of lung disease in cystic fibrosis. N. Engl. J. Med. 322, 1189-1194.
18. Knowles, M.R., Clarke, L.L., and Boucher, R.C. (1991). Activation by extracellular nucleotides of chloride secretion in the airway epithelia of patients with cystic fibrosis. N. Engl. J. Med. 325, 533-538.
19. Konstan, M.W., and Berger, M. (1993). Infection and inflammation of the lung in cystic fibrosis. In Cystic Fibrosis, P.B. Davis, ed. (New York: Marcel Dekker, Inc.), pp. 219-276.
20. Larivée, P., Levine, S.J., Rieves, R.D., and Shelhamer, J.H. (1994). Airway inflammation and mucous hypersecretion. In Airway Secretion, T. Takishima and S. Shimura, eds. (New York: Marcel Dekker, Inc.), pp. 469-512.
21. Lehrer, R.I., Lichtenstein, A.K., and Ganz, T. (1993). Defensins: anti-microbial and cytotoxic peptides of mammalian cells. Annu. Rev. Immunol. 11, 105-128.
22. Levine, S.J., Larivée, P., Logun, C., Angus, C.W., Ognibene, F.P., and Shelhamer, J.H. (1995). Tumor necrosis factor-α induces mucin hypersecretion and MUC-2 gene expression by human airway epithelial cells. Am. J. Respir. Cell Mol. Biol. 12, 196-204.
23. Martin, E., Ganz, T., and Lehrer, R.I. (1995). Defensins and other endogenous peptide antibiotics of vertebrates. J. Leukoc. Biol. 58, 128-136.
24. Pier, G.B., Grout, M., Zaidi, T.S., Olsen, J.C., Johnson, L.G., Yankaskas, J.R., and Goldberg, J.B. (1996). Role of mutant CFTR in hypersusceptibility of cystic fibrosis patients to lung infections. Science 271, 64-67.
25. Pilewski, J.M., and Frizzell, R.A. (1995). How do cystic fibrosis transmembrane conductance regulator mutations produce lung disease? Curr. Opin. Pulm. Med. 1, 435-443.
26. Quinton, P.M. (1984). Exocrine glands. In Cystic Fibrosis, L.M. Taussig, ed. (New York: Thieme-Statton, Inc.), pp 338-375.
27. Quinton, P.M. (1990). Cystic fibrosis: a disease in electrolyte transport. FASEB J. 4, 2709-2717.
28. Quinton, P.M. (1994). Viscosity versus composition in airway pathology. Am. J. Respir. Crit. Care Med. 149, 6-7.
29. Ramsey, B.W., Wentz, K.R., Smith, A.L., Richardson, M., Williams-Warren, J., Hedges, D.L., Gibson, R., Redding, G.J., Lent, K., and Harris, K. (1991). Predictive value of oropharyngeal cultures for identifying lower airway bacteria in cystic fibrosis patients. Am. Rev. Respir. Dis. 144, 331-337.
30. Regnis, J.A., Robinson, M., Bailey, D.L., Cook, P., Hooper, P., Chan, H.-K., Gonda, I., Bautovich, G., and Bye, P.T.P. (1994). Mucociliary clearance in patients with cystic fibrosis and in normal subjects. Am. J. Respir. Grit. Care Med. 150, 66-71.
31. Riordan, J.R. (1993). The cystic fibrosis transmembrane conductance regulator. Annu. Rev. Physiol. 55, 609-630.
32. Saiman, L., and Prince, A. (1993). Pseudomonas aeruginosa pili bind to asialoGM1 which is increased on the surface of cystic fibrosis epithelial cells. J. Clin. Invest. 92, 1875-1880.
33. Sanchis, J., Dolovich, M., Rossman, C., Wilson, W., and Newhouse, M. (1973). Pulmonary mucociliary clearance in cystic fibrosis. N. Engl. J. Med. 288, 651-654.
34. Sheppard, D.N., Carson, M.R., Ostedgaard, L.S., Denning, G.M., and Welsh, M.J. (1994). Expression of cystic fibrosis transmembrane conductance regulator in a model epithelium. Am. J. Physiol. 266, L405-L413.
35. Smith, J.J., and Welsh, M.J. (1993). Fluid and electrolyte transport by cultured human airway epithelia. J. Clin. Invest. 91, 1590-1597.
36. Smith, J.J., Karp, P.H., and Welsh, M.J. (1994). Defective fluid transport by cystic fibrosis airway epithelia. J. Clin. Invest. 93, 1307-1311.
37. Welsh, M.J., Tsui, L.-C., Boat, T.F., and Beaudet, A.L. (1995). Cystic fibrosis. In The Metabolic and Molecular Basis of Inherited Disease, C.R. Scriver, A.L. Beaudet, W.S. Sly, and D. Valle, eds. (New York: McGraw-Hill, Inc.), pp. 3799-3876.
38. Wilmott, R.W., Kassab, J.T., Kilian, P.L., Benjamin, W.R., Douglas, S.D., and Wood, R.E. (1990). Increased levels of interleukin-1 in bronchoalveolar washings from children with bacterial pulmonary infections. Am. Rev. Respir. Dis. 142, 365-368.
39. Wine, J.J. (1995). How do CFTR mutations cause cystic fibrosis? Curr. Biol. 5, 1357-1359.
40. Yamaya, M., Finkbeiner, W.E., Chun, S.Y., and Widdicombe, J.H. (1992). Differentiated structure and function of cultures from human tracheal epithelium. Am. J. Physiol. 262, L713-L724.
41. Yeates, D.B., Sturgess, J.M., Kahn, S.R., Levison, H., and Aspin, N. (1976). Mucociliary transport in trachea of patients with cystic fibrosis. Arch. Dis. Child. 51, 28-33.
42. Zabner, J., Couture, L.A., Smith, A.E., and Welsh, M.J. (1994). Correction of cAMP-stimulated fluid secretion in cystic fibrosis airway epithelia: efficiency of adenovirus-mediated gene transfer in vitro. Hum. Gene Ther. 5, 585-593.